Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: J Stone who wrote (29358)	11/5/1999 4:03:00 PM
From: bob zagorin	Read Replies (2) \| Respond to of 32384

technicals are mixed. BOP is modestly postive; Moneystream is still low but the stock is moving off a 3 mos base. it's been a tough year so there's probably still some tax selling. this is for sure. all three of those big pharms PFE, AHP & WLA have investments in LGND technology (according to henry). IOW, that is part of the asset base that they covet among each other. how much, i don't know but it does, apparently, have value to them. also, murphy (CTSL), says LGND will go before FDA in early december for oral Targretin for lyphoma. FWIW.